Blog

Amneal Pharmaceuticals (AMRX) reported $695.42 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 5.5%. EPS of $0.21 for the same period compares to $0.14

DTE Energy (DTE) reported $-999 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 130.8%. EPS of $2.10 for the same period compares to $1.67 a year ago.

For the quarter ended March 2025, Northern Oil and Gas (NOG) reported revenue of $576.95 million, up 8.4% over the same period last year. EPS came in at $1.33, compared to $1.28 in the year-ago

For the quarter ended March 2025, T. Rowe Price (TROW) reported revenue of $1.76 billion, up 0.8% over the same period last year. EPS came in at $2.23, compared to $2.38 in the year-ago quarter.

The

Exxon Mobil (XOM) reported $83.13 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 0.1%. EPS of $1.76 for the same period compares to $2.06 a year ago.

WisdomTree, Inc. (WT) reported $108.08 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 11.6%. EPS of $0.16 for the same period compares to $0.12 a year

For the quarter ended March 2025, Magna (MGA) reported revenue of $10.07 billion, down 8.2% over the same period last year. EPS came in at $0.78, compared to $1.08 in the year-ago quarter.

The

Moderna (MRNA) reported $108 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 35.3%. EPS of -$2.52 for the same period compares to -$3.07 a year ago.

The

For the quarter ended March 2025, Westlake Chemical (WLK) reported revenue of $2.85 billion, down 4.3% over the same period last year. EPS came in at -$0.31, compared to $1.34 in the year-ago

Xenia Hotels & Resorts (XHR) reported $288.93 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 8%. EPS of $0.51 for the same period compares to $0.08 a

For the quarter ended March 2025, Cactus, Inc. (WHD) reported revenue of $280.32 million, up 2.3% over the same period last year. EPS came in at $0.73, compared to $0.75 in the year-ago quarter.

The

Wendy's (WEN) reported $523.47 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.1%. EPS of $0.20 for the same period compares to $0.23 a year ago.

The

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

One of our most popular

From a technical perspective, Celestica (CLS) is looking like an interesting pick, as it just reached a key level of support. CLS recently overtook the 50-day moving average, and this suggests a